Early parenteral supplementation with glutamine dipeptide for acute myeloid leukaemia patients receiving high dose chemotherapy
Journal of High Institute of Public Health [The]. 2015; 45 (2): 42-51
in English
| IMEMR
| ID: emr-185286
ABSTRACT
Background:
Glutamine dipeptide [Gln] is one of conditionally essential amino acids that have a crucial role in cancer
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Type of study:
Controlled clinical trial
Language:
English
Journal:
J. High Inst. Public Health
Year:
2015
Similar
MEDLINE
...
LILACS
LIS